Episode
Part 3 - Hypertrophic Cardiomyopathy: Hidden in Plain Sight
- Podcast
- DoctoRx Unscripted
- Published
- Feb 25, 2026
- Duration seconds
- 2291
- Processing state
not_requested- Canonical source
- https://doctorx-unscripted.podbean.com/e/part-3-hypertrophic-cardiomyopathy-hidden-in-plain-sight-the-movement/
Actions
POST https://stenobird.com/v1/public/podcasts/doctorx-unscripted-7398035/episodes/part-3-hypertrophic-cardiomyopathy-hidden-in-plain-sight/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/doctorx-unscripted-7398035/part-3-hypertrophic-cardiomyopathy-hidden-in-plain-sight.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Join Dr. Tania Small, head of Medical Affairs at Bristol Myers Squibb, for a special edition of DoctoRx Unscripted, focused on hypertrophic cardiomyopathy (HCM)—one of the most common inherited cardiac diseases and one of the most frequently missed. In Part 3, Dr. Small sits down with patient advocate Lisa Salberg, founder of the Hypertrophic Cardiomyopathy Association (HCMA), to explore how a personal diagnosis evolved into a global movement—helping to establish more than 60 Centers of Excellence around the world. The conversation reinforces why embedding the patient voice early is essential to advancing cardiovascular medicine.